Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Varun Hiremath, CEO of Fair Deal Wealth Advisors Received Times Applaud Trendsetter Awards 2024 Business
  • Cosmic Scanner Launches the Ultimate Online Group Trip Marketplace for Young Adults Business
  • Surat-native Lajja Shah keeps Gujarat’s pride and culture alive on European soil Entertainment
  • Home Investment Magic: Where Cash Comes Back Like a Boomerang! Business
  • Chennai Blitz Keep PVL 2025 Hopes Alive with Nail-Biting Win Over Defenders Press Release
  • Vedanta Aluminium conducts ‘Suraksha Sarathi’,a mega road safety awareness drive Business
  • Justice Sambare, Justice Mrs Gauri Godse, Judge Srinivas Agarwal, and Judge Anirudha Pratinidhi inaugurate Annexe Palghar Court -World News Network National
  • Jazim Sharma Releases Soul-Stirring Shiv Bhajan O Shiva for Shemaroo Bhakti Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Life After Weight Loss Surgery – Ckosmic Health City Guide Health
  • Special hair loss treatment for Covid-19 patients launched by Advanced Wellness Health
  • ‘Immunotherapy’ to treat Autism Spectrum Disorder, Dr A M Reddy’s Autism Centre sparks a new hope Health
  • From Treating Eczema With Ayurveda To Building A Brand Catering 10,00,000+ Customers- Meet The Founders Health
  • Dietitian Amandeep Soni Empowers Health Journeys Through Singh Nutri Diet Health
  • CityPlus Hospital Sets New Milestone with Robotic Total Knee Replacement Surgery Led by Dr. Rohit Damor Health

Recent Posts

  • Iti Acharya Champions Women-Centric Storytelling Across RIFF and BIFFES 2026
  • OMG Navyashree looks exactly like Divya Bharti, She has won many beauty contests ,may soon make her Bollywood debut
  • NIS Management Limited Receives ICRA Reaffirmation on Rs 105.87 Cr Rated Facilities; Outlook Upgraded to Positive
  • IBS Treatment in Ayurveda: Causes, Symptoms and Natural Permanent Relief by Kalpataru Ayurvediya Chikitsalaya
  • Krishival Foods Growth Trajectory Accelerates; 9MFY26 Revenue Tally Nears FY25 Level

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Plutus’ Teen Founders Bring Algorithmic Edge, Unlocking Superior Alpha for Quantitative Investors Finance
  • The Journey Of Gaurang Doshi, A Man Who Rose Like A Phoenix After A Sabbatical From Films Lifestyle
  • A World Tour Turns Into a Murderous Hunt in 7 by Dr. Praveen Srinivasan Business
  • Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 23.67 crore in Q1 FY25, growth of 24.51 Percent Y-o-Y Business
  • Veganuary takes India by storm- ranks 3rd globally Press Release
  • International Women’s Day: Introducing Inspiring Women Leaders, Shaping the Future Business
  • VRaZ Academy, Best Institute for IIT-JEE and NEET in Thane, Manpada, and Kalyan Education
  • Diljit Dosanjh Unveils ‘Aura’: Pop Pulse or Hype Mirage? Entertainment

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme